<?xml version='1.0' encoding='ISO-8859-1'?>
<?xml-stylesheet href="/css/rss20.xsl" type="text/xsl"?>
<rss version='2.0' xmlns:pheedo="http://www.pheedo.com/namespace/pheedo">
	<channel>
		<title>Acute Myeloid Leukemia News</title>
		<link>http://news.cancerbasics.info/acute_myeloid_leukemia_news.html</link>
		<description>Latest Acute Myeloid Leukemia News updated hourly. Subscribe and stay informed on latest cancer news for acute myeloid leukemia.</description>
		<language>en-us</language>
		<webMaster>cancerbasics.info@gmail.com</webMaster>
		<pubDate>Sun, 01 Nov 2009 14:48:21 +0100</pubDate>
		<lastBuildDate>Sun, 01 Nov 2009 14:48:21 +0100</lastBuildDate>
		<category>Health</category>
		<docs>http://blogs.law.harvard.edu/tech/rss</docs>
		<ttl>60</ttl>
		<image>
			<url>http://news.cancerbasics.info/images/feedfavicon.png</url>
			<title>Acute Myeloid Leukemia News</title>
			<link>http://news.cancerbasics.info/acute_myeloid_leukemia_news.html</link>
			<description>Latest Acute Myeloid Leukemia News updated hourly. Subscribe and stay informed on latest cancer news for acute myeloid leukemia.</description>
			<width>88</width>
			<height>88</height>
		</image>
		<item>
			<title>Latest Acute Myeloid Leukemia News</title>
			<link>http://news.cancerbasics.info/acute_myeloid_leukemia_news.html</link>
			<description>Latest news for Acute Myeloid Leukemia updated every 30 minutes, dedicated for patients, caregivers, physicians and researchers whose interest are acute myeloid leukemia, acute myelogenous leukemia, aml, leukemia.</description>
			<pubDate>Sun, 01 Nov 2009 14:48:21 +0100</pubDate>
		</item>
		<item>
			<title>Cancer Detection Lab Tests Online</title>
			<link>http://news.cancerbasics.info/cancernews/pmdcancer/61374</link>
			<description>Order cancer detection lab tests online safely and securely. Physicians Order Included. Always Secure. - Read more ...</description>
			<pubDate>Sun, 01 Nov 2009 14:48:21 +0100</pubDate>
		</item>
		<item>
			<title>Sunesis Completes Enrollment Of Voreloxin REVEAL-1 Trial In Acute Myeloid Leukemia </title>
			<link>http://www.pheedcontent.com/click.phdo?i=02c16092ef33fa2d5455bcb6ed38bb78</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://us.rd.yahoo.com/dailynews/rss/search/acute+myeloid+leukemia/SIG=11nl0qhsm/*http%3A//www.medicalnewstoday.com/articles/169383.php</pheedo:origLink>
			<description>Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy.&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://ads.pheedo.com/click.phdo?s=02c16092ef33fa2d5455bcb6ed38bb78&amp;p=1&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://ads.pheedo.com/img.phdo?s=02c16092ef33fa2d5455bcb6ed38bb78&amp;p=1&quot;/&gt;&lt;/a&gt;
&lt;!-- foo --&gt;</description>
			<pubDate>Sat, 31 Oct 2009 10:20:00 +0100</pubDate>
		</item>
		<item>
			<title>Sunesis Completes Enrollment of Voreloxin REVEAL-1 Trial in Acute Myeloid Leukemia </title>
			<link>http://www.pheedcontent.com/click.phdo?i=bfa0cbcc59ef13f1656eed9663211475</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://us.rd.yahoo.com/dailynews/rss/search/acute+myeloid+leukemia/SIG=11oa4ldl6/*http%3A//biz.yahoo.com/prnews/091030/sf02282.html?.v=1</pheedo:origLink>
			<description>Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia patients who are unlikely to benefit from standard induction chemotherapy.&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://ads.pheedo.com/click.phdo?s=bfa0cbcc59ef13f1656eed9663211475&amp;p=1&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://ads.pheedo.com/img.phdo?s=bfa0cbcc59ef13f1656eed9663211475&amp;p=1&quot;/&gt;&lt;/a&gt;
&lt;!-- foo --&gt;</description>
			<pubDate>Fri, 30 Oct 2009 11:00:00 +0100</pubDate>
		</item>
		<item>
			<title>Sunesis Completes Enrollment of Voreloxin REVEAL-1 Trial in Acute Myeloid Leukemia </title>
			<link>http://www.pheedcontent.com/click.phdo?i=e1f69bfb8dfe2d2af12cba6926cb6d98</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://us.rd.yahoo.com/dailynews/rss/search/acute+myeloid+leukemia/SIG=14jdth4dt/*http%3A//www.redorbit.com/news/health/1777949/sunesis_completes_enrollment_of_voreloxin_reveal1_trial_in_acute_myeloid/index.html?source=r_health</pheedo:origLink>
			<description>SOUTH SAN FRANCISCO, Calif., Oct. 30 /PRNewswire-FirstCall/ - Sunesis Pharmaceuticals, Inc.&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://ads.pheedo.com/click.phdo?s=e1f69bfb8dfe2d2af12cba6926cb6d98&amp;p=1&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://ads.pheedo.com/img.phdo?s=e1f69bfb8dfe2d2af12cba6926cb6d98&amp;p=1&quot;/&gt;&lt;/a&gt;
&lt;!-- foo --&gt;</description>
			<pubDate>Fri, 30 Oct 2009 14:13:12 +0100</pubDate>
		</item>
		<item>
			<title>Leukemia Ribbon</title>
			<link>http://news.cancerbasics.info/cancernews/ribbonleu/leukemia-awareness-ribbon-lapel-pin</link>
			<description>Leukemia Support Ribbon Lapel Pins. - Made in U.S.A. - Help Increase Leukemia Awareness and Early Detection.</description>
			<pubDate>Sun, 01 Nov 2009 14:48:21 +0100</pubDate>
		</item>
		<item>
			<title>Adult Acute Myeloid Leukemia</title>
			<link>http://www.pheedo.com/click.phdo?i=96042fe17bd0523680c013a98e34416b</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1P3-984554411.html</pheedo:origLink>
			<description>Acute myeloid leukemia  is a group of several different diseases, the treatment and outcome of which depend on several factors, including leukemia karyotype, patient age, and comorbid conditions. Despite advances in understanding the molecular biology of AML, its treatment remains challenging. ...&lt;br style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://www.pheedo.com/click.phdo?s=96042fe17bd0523680c013a98e34416b&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?s=96042fe17bd0523680c013a98e34416b&quot;/&gt;&lt;/a&gt;
&lt;img src=&quot;http://www.pheedo.com/feeds/tracker.php?i=96042fe17bd0523680c013a98e34416b&quot; style=&quot;display: none;&quot; border=&quot;0&quot; height=&quot;1&quot; width=&quot;1&quot; alt=&quot;&quot;/&gt;
</description>
		</item>
		<item>
			<title>Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series</title>
			<link>http://www.pheedcontent.com/click.phdo?i=16b724a633c7b36a7873c9c2da152521</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1P3-1667026081.html</pheedo:origLink>
			<description>This study retrospectively analyzed 8 cases of biphenotypic acute leukemia  in respect of morphology, immune phenotype, karyotype, and clinical manifestations. Six patients had myeloid plus T lymphoid, and 2 cases had myeloid plus B-lymphoid immune phenotypic markers. Because selection of an ...&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://www.pheedo.com/click.phdo?s=16b724a633c7b36a7873c9c2da152521&amp;p=1&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?s=16b724a633c7b36a7873c9c2da152521&amp;p=1&quot;/&gt;&lt;/a&gt;
</description>
		</item>
		<item>
			<title>Differentiation of Acute Myeloid Leukemia from B- and T-Lineage Acute Lymphoid Leukemias by Real-Time Quantitative Reverse Transcription-PCR of Lineage Marker mRNAs</title>
			<link>http://www.pheedo.com/click.phdo?i=6447ab31f82b77bf0f550720f76a75e4</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1P3-659063491.html</pheedo:origLink>
			<description>Background: Flow cytometry of lineage markers is useful in the classification of leukemias. Our aim was to assess whether the study of lineage genes at the RNA level would enable differentiation of acute myeloid leukemias  from B-and T-lineage acute lymphoid leukemias . Methods: We ...&lt;br style=&quot;clear: both;&quot;/&gt;
&lt;img alt=&quot;&quot; style=&quot;border: 0; height:1px; width:1px;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?i=6447ab31f82b77bf0f550720f76a75e4&quot; height=&quot;1&quot; width=&quot;1&quot;/&gt;
&lt;img src=&quot;http://www.pheedo.com/feeds/tracker.php?i=6447ab31f82b77bf0f550720f76a75e4&quot; style=&quot;display: none;&quot; border=&quot;0&quot; height=&quot;1&quot; width=&quot;1&quot; alt=&quot;&quot;/&gt;
</description>
		</item>
		<item>
			<title>Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage</title>
			<link>http://www.pheedo.com/click.phdo?i=3a29f18548fc7626ab94eddafefdb1fb</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1P3-321423741.html</pheedo:origLink>
			<description>* Acute leukemias demonstrating immunophenotypic features of more than 1 cell lineage are referred to as acute leukemias of ambiguous lineage in the new World Health Organization classification system. A subtype of leukemia of ambiguous lineage is biphenotypic acute leukemia in which the malignant ...&lt;br style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://www.pheedo.com/click.phdo?s=3a29f18548fc7626ab94eddafefdb1fb&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?s=3a29f18548fc7626ab94eddafefdb1fb&quot;/&gt;&lt;/a&gt;
&lt;img src=&quot;http://www.pheedo.com/feeds/tracker.php?i=3a29f18548fc7626ab94eddafefdb1fb&quot; style=&quot;display: none;&quot; border=&quot;0&quot; height=&quot;1&quot; width=&quot;1&quot; alt=&quot;&quot;/&gt;
</description>
		</item>
		<item>
			<title>Immunoreactivity of MIC2  and Terminal Deoxynucleotidyl Transferase in Bone Marrow Clot and Core Specimens of Acute Myeloid Leukemias and Myelodysplastic Syndromes</title>
			<link>http://www.pheedo.com/click.phdo?i=b955ec880e2b6e94f70c135e151ad0ef</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1P3-995969581.html</pheedo:origLink>
			<description>Context.-MIC2 ("thymus leukemia") antigen has been shown to be expressed by T cells and monocytes, as well as B cells and granulocyte-lineage cells. It is most intensely expressed by the most immature thymus T-lineage cells and is more intensely expressed by CD34-positive/CD33-positive myeloid ...&lt;br style=&quot;clear: both;&quot;/&gt;
&lt;img alt=&quot;&quot; style=&quot;border: 0; height:1px; width:1px;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?i=b955ec880e2b6e94f70c135e151ad0ef&quot; height=&quot;1&quot; width=&quot;1&quot;/&gt;
&lt;img src=&quot;http://www.pheedo.com/feeds/tracker.php?i=b955ec880e2b6e94f70c135e151ad0ef&quot; style=&quot;display: none;&quot; border=&quot;0&quot; height=&quot;1&quot; width=&quot;1&quot; alt=&quot;&quot;/&gt;
</description>
		</item>
		<item>
			<title>County clerk says she has leukemia At a glanceLaramie County Clerk Debbye Lathrop announced Thursday that she has acute myeloid leukemia. It is the same type of blood cell cancer that afflicted the late U.S. Sen. Craig Thomas, R-Wyo.</title>
			<link>http://www.pheedo.com/click.phdo?i=8e8e1df0f5c3431a8b3cf4c3d25030fb</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1P2-15875910.html</pheedo:origLink>
			<description>Debbye Lathrop announced that as she begins treatment for acute myeloid leukemia, her office is staffed with "very capable people who will keep things running smoothly." By Jodi Rogstad and Jennifer Frazer news@wyomingnews.com CHEYENNE - Laramie County Clerk Debbye Lathrop announced Thursday that ...&lt;br style=&quot;clear: both;&quot;/&gt;
&lt;img alt=&quot;&quot; style=&quot;border: 0; height:1px; width:1px;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?i=8e8e1df0f5c3431a8b3cf4c3d25030fb&quot; height=&quot;1&quot; width=&quot;1&quot;/&gt;
&lt;img src=&quot;http://www.pheedo.com/feeds/tracker.php?i=8e8e1df0f5c3431a8b3cf4c3d25030fb&quot; style=&quot;display: none;&quot; border=&quot;0&quot; height=&quot;1&quot; width=&quot;1&quot; alt=&quot;&quot;/&gt;
</description>
		</item>
		<item>
			<title>The Value of CD64 Expression in Distinguishing Acute Myeloid Leukemia With Monocytic Differentiation From Other Subtypes of Acute Myeloid Leukemia: A Flow Cytometric Analysis of 64 Cases</title>
			<link>http://www.pheedo.com/click.phdo?i=6e2758ce762edc22ede3ffbfd9c142d5</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1P3-1272518731.html</pheedo:origLink>
			<description>Context.-Flow cytometric immunophenotyping is a useful ancillary tool in the diagnosis and subclassification of acute myeloid leukemias . A recent study concluded that CD64 is sensitive and specific for distinguishing AMLs with a monocytic component  from other AML ...&lt;br style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://www.pheedo.com/click.phdo?s=6e2758ce762edc22ede3ffbfd9c142d5&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?s=6e2758ce762edc22ede3ffbfd9c142d5&quot;/&gt;&lt;/a&gt;
&lt;img src=&quot;http://www.pheedo.com/feeds/tracker.php?i=6e2758ce762edc22ede3ffbfd9c142d5&quot; style=&quot;display: none;&quot; border=&quot;0&quot; height=&quot;1&quot; width=&quot;1&quot; alt=&quot;&quot;/&gt;
</description>
		</item>
		<item>
			<title>Researchers from Medical University of Graz, Division of Hematology describe findings in acute myeloid leukemia therapy.</title>
			<link>http://www.pheedcontent.com/click.phdo?i=8b2a9ee2994408b2d654ab73248c0984</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1G1-202867536.html</pheedo:origLink>
			<description>A new study, 'Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations,' is now available. According to recent research from Graz, Austria, "We recently described oncogenic and anti-apoptotic C-RAF germline ...&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://ads.pheedo.com/click.phdo?s=8b2a9ee2994408b2d654ab73248c0984&amp;p=1&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://ads.pheedo.com/img.phdo?s=8b2a9ee2994408b2d654ab73248c0984&amp;p=1&quot;/&gt;&lt;/a&gt;
&lt;!-- foo --&gt;</description>
		</item>
		<item>
			<title>Research from University of Rochester in acute myeloid leukemia genetics provides new insights.</title>
			<link>http://www.pheedcontent.com/click.phdo?i=ce376a8f13fe683a85a009822435846d</link>
			<pheedo:origLink>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1G1-183190740.html</pheedo:origLink>
			<description>New research, 'Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia,' is the subject of a report. According to a study from the United States, "Mutations in exon 12 of the nucleophosmin gene  that cause the encoded protein to abnormally relocate to the ...&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;br clear=&quot;both&quot; style=&quot;clear: both;&quot;/&gt;
&lt;a href=&quot;http://www.pheedo.com/click.phdo?s=ce376a8f13fe683a85a009822435846d&amp;p=1&quot;&gt;&lt;img alt=&quot;&quot; style=&quot;border: 0;&quot; border=&quot;0&quot; src=&quot;http://www.pheedo.com/img.phdo?s=ce376a8f13fe683a85a009822435846d&amp;p=1&quot;/&gt;&lt;/a&gt;
</description>
		</item>
		<item>
			<title>Combination of High Dose QUADRAMET and Chemotherapy Shows Promise for Treatment of High-Risk Acute Myeloid Leukemia.</title>
			<link>http://news.cancerbasics.info/linkout/oaml.php?out=http://www.highbeam.com/doc/1G1-151535985.html</link>
			<description>Data published in peer-reviewed journal Leukemia  and amp; Lymphoma PRINCETON, N.J., Sept. 18 /PRNewswire-FirstCall/ - Cytogen Corporation today announced the publication of new data relating to the Company's QUADRAMET (samarium Sm-153 lexidronam injection) product. The publication, "Marrow ...</description>
		</item>
		<item>
			<title>Cancer Supplements</title>
			<link>http://news.cancerbasics.info/cancernews/supplements/7210024</link>
			<description>Discount Natural Cancer Supplements and Products and natural vitamin supplements at 20% to 70% off retail. Read more ...</description>
			<pubDate>Sun, 01 Nov 2009 14:48:21 +0100</pubDate>
		</item>
	</channel>
</rss>